PTPRC and neoplasm: When comparing AIN‐treated to PLX‐treated tumor animals, we observed no differences in tumor‐infiltrating immune cells (Figure 6b,e), including T‐cells, neutrophils, monocytes, and tumor‐associated macrophages, both total number and as percentage of total CD45+ cells (Figure 6c,e).